McKesson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade McKesson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MCK

McKesson Corp. engages in providing healthcare services. It operates through the following segments: North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions (RxTS), and Medical-Surgical Solutions. 

CEO
Brian Scott Tyler
CEOBrian Scott Tyler
Employees
43,000
Employees43,000
Headquarters
Irving, Texas
HeadquartersIrving, Texas
Founded
1833
Founded1833
Employees
43,000
Employees43,000

MCK Key Statistics

Market cap
93.24B
Market cap93.24B
Price-Earnings ratio
19.73
Price-Earnings ratio19.73
Dividend yield
0.42%
Dividend yield0.42%
Average volume
1.35M
Average volume1.35M
High today
$781.27
High today$781.27
Low today
$758.65
Low today$758.65
Open price
$760.70
Open price$760.70
Volume
981.96K
Volume981.96K
52 Week high
$999.00
52 Week high$999.00
52 Week low
$637.00
52 Week low$637.00

Stock Snapshot

The current McKesson(MCK) stock price is $771.00, with a market capitalization of 93.24B. The stock trades at a price-to-earnings (P/E) ratio of 19.73 and offers a dividend yield of 41.9%.

As of 2026-06-06, McKesson(MCK) stock has fluctuated between $758.65 and $781.27. The current price stands at $771.00, placing the stock +1.6% above today's low and -1.3% off the high.

The McKesson(MCK)'s current trading volume is 981.96K, compared to an average daily volume of 1.35M.

During the past year, McKesson(MCK) stock moved between $637.00 at its lowest and $999.00 at its peak.

During the past year, McKesson(MCK) stock moved between $637.00 at its lowest and $999.00 at its peak.

MCK News

TipRanks 15h
McKesson Buy Rating Reaffirmed as GLP-1 Positioning Supports Outlook; $900 Price Target Maintained

In a report released yesterday, Allen Lutz from Bank of America Securities maintained a Buy rating on McKesson, with a price target of $900.00. Unlock trusted,...

Investing.com 1d
Airbnb, McKesson, Gilead and more set to report earnings Thursday - Investing.com

...

Airbnb, McKesson, Gilead and more set to report earnings Thursday - Investing.com
Simply Wall St 3d
McKesson Apollo Deal Reframes Medical Surgical Spin Off And Investor Story

McKesson (NYSE:MCK) is receiving a $1.25b minority investment from Apollo in its Medical Surgical Solutions business. The deal values Medical Surgical Solution...

McKesson Apollo Deal Reframes Medical Surgical Spin Off And Investor Story

Analyst ratings

90%

of 21 ratings
Buy
90.5%
Hold
9.5%
Sell
0%

More MCK News

TipRanks 4d
McKesson closes investment with Apollo Funds for minority interest in MMS

McKesson (MCK) announced the successful completion of the previously announced minority ownership interest investment from funds managed by affiliates of Apollo...

Simply Wall St 6d
McKesson’s ASCO 2026 Data Highlights Evolving Role In Community Oncology

McKesson (NYSE:MCK) supported new research presented at ASCO 2026 by The US Oncology Network. The study found that advanced practice provider led consult model...

McKesson’s ASCO 2026 Data Highlights Evolving Role In Community Oncology

People also own

Based on the portfolios of people who own MCK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.